ABILIFY MYCITE® is the first FDA-approved digital medicine system for patients. It consists of a pill that, when ingested, transmits a signal to a wearable patch on the patient. This patch then communicates with a mobile app to track medication adherence.
The system also tracks rest and activity levels and allows patients to record mood levels. Patients can then choose to transmits this information to their heath care providers or caregivers through secure web portals.
As a FDA-regulated product, MYCITE depends on human factor studies and development of new features that focus on a user’s comprehension of tasks in order to optimize the efficiency, safety, and ease of learning for its targeted users.
This work is under strict NDA. I would be happy to clarify my involvement in more detail during private interviews.
I was the lead designer on a team of four designers. We were responsible for the design and documentation of the iOS and Android mobile apps, web portals, custom human factors tools, and human training tools for product demonstration and support. We also provided technical support for clinical studies, testing, and user acceptance validation.